Company
Soricimed
Precision Therapies for the Treatment of Solid Tumor Cancers
Also known as Soricimed Biopharma
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Moncton, N.B., Canada
- Legal name
- Soricimed Biopharma
- soricimed.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Soricimed we are using our proprietary TRPV6 peptide ligands to create a new class of targeted radioligand therapies and peptide-drug conjugates.
Funding snapshot
- Total raised
- $2.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $2.8M2021-07-23
Funding rounds
- Round, 2021
- $2.8M2021-07-23, SEC form D sold, 45 investors
- Round, 2011
- $109K2011-09-30, SEC form D sold, 2 investors
Loading relationship preview